StockDuty ← Dashboard Oct 28, 2026 01:27 PM ET
SignalTech/AI

Anthropic is running its own drug programs after acquiring a one-person biotech

Anthropic acquired a one-person biotech to launch its own drug programs.

What happened: Anthropic released early results from drug development work with six partners, including Bristol Myers Squibb, after acquiring a one-person biotech and running its own drug programs. Why it matters: The results mark Anthropic's move into drug development alongside established pharmaceutical partners, extending its work beyond its core business.
Anthropic released early results from drug development work with six partners, including Bristol Myers Squibb, after acquiring a one-person biotech and running its own drug programs.
The results mark Anthropic's move into drug development alongside established pharmaceutical partners, extending its work beyond its core business.
Sources